adults having used a GLP-1, like Ozempic, Wegovy, and Mounjaro, at some point, including 40% with diabetes and 25% with heart disease, the broader health implications of this class of drugs are of increasing interest to researchers
Beverly Hills-based celebrity dermatologist Harold Lancer is one of the main men behind the faces (and bodies) of Hollywoods elite, but the latest flux of technology into his Rodeo Drive clinic is about to put him on the map, again
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol
Some individuals may experience greater or lesser weight reduction, as each persons journey is unique
These studies are researching the benefit of taking GLP-1 drugs for the treatment of cardiovascular disease regardless of the patient's weight
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with comorbidities